MARIMED INC.
MRMD · OTCMCIK 1522767fmd_06XAH62QKFKD47SZKTV6J0K42ZManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2011 to Sep 30, 2026, 63 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 4 | 6 | 12 | 46 | 51 | 121 | 134 | 149 | 158 | 160 |
| Rental revenue | – | – | 5 | 10 | 14 | 7 | 4 | 2 | 1 | – |
| Cost of revenue | 2 | 2 | 4 | 27 | 20 | 55 | 70 | 83 | 95 | 102 |
| Net interest income | 0 | – | – | – | – | – | – | – | – | – |
| Gross profit | 2 | 4 | 8 | 19 | 31 | 66 | 64 | 66 | 63 | 58 |
| Realized investment gains (losses) | – | – | – | – | (0) | (1) | (1) | (0) | (0) | 0 |
| Research and development | – | – | – | – | – | – | – | – | – | – |
| Selling, general and administrative | 1 | – | – | – | – | – | – | – | – | – |
| Total operating expenses | 1 | 4 | 13 | 60 | 17 | 39 | 44 | 52 | 60 | 61 |
| Compensation and benefits | – | – | – | – | – | 8 | 14 | 23 | 27 | 29 |
| Operating income | 1 | 0 | (5) | (42) | 15 | 27 | 20 | 14 | 3 | (3) |
| Interest expense | (0) | 1 | 4 | 13 | 10 | 2 | 2 | 9 | 7 | 8 |
| Other non-operating income (expense) | 0 | 1 | (8) | (40) | (10) | (3) | (1) | (21) | (7) | (8) |
| Income before taxes | – | – | – | (82) | 4 | 24 | 20 | (7) | (4) | (11) |
| Income tax expense | – | – | – | 0 | 2 | 16 | 6 | 9 | 8 | 4 |
| Net income from continuing operations | – | – | – | (82) | 2 | 8 | 14 | (16) | (12) | (14) |
| Net income | (0) | (1) | (14) | (81) | 2 | 7 | 13 | (16) | (12) | (14) |